期刊文献+

阴道光滑念珠菌耐药性及氟康唑耐药相关基因的表达

Drug resistance and expression of gene related to fluconazole resistance in Canadida glabrata isolated from vagina
下载PDF
导出
摘要 目的研究阴道中光滑念珠菌耐药性及氟康唑耐药相关基因的表达。方法分离、鉴定阴道分泌物中的光滑念珠菌,并进行药敏实验。抽提光滑念珠菌总RNA,通过RT-PCR检测耐药基因CDR1、CDR2和ERG11的相对表达量。结果光滑念珠菌对制霉菌素、两性霉素B的药物敏感性最好,5-氟胞嘧啶次之,对唑类药物的耐药率(41.00%~67.00%)较高;对氟康唑的耐药率为44.00%。RT-PCR结果显示,光滑念珠菌氟康唑耐药组CDR1、CDR2和ERG11基因高表达。结论光滑念珠菌对常用抗真菌药物的耐药率呈上升趋势。光滑念珠菌耐药基因CDR1、CDR2和ERG11的高表达,与临床光滑念珠菌对氟康唑耐药有关。 Objective To explore the drug resistance and expression of fluconazole-resistant genes in Candida glabrata clinical isolates from vagina.Methods Candida glabrata in vaginal secretions were isolated,identified and detected for drug resistance.Total RNA of Candida glabrata isolates were extracted,the expression of CDR1,CDR2 and ERG11 were detected by real-time polymerase chain reaction(PCR).Results Candida glabrata were more sensitive to nystatin and amphotericine B,followed by 5-fluorocytosine,but resistant to azoles antifungal drugs,with resistant rate from 41.00% to 67.00%.The resistant rate of Candida glabrata clinical isolates to fluconazole was 44.00%.The drug resistance genes CDR1,CDR2 and Erg11 were overexpressed in sluconazole resistant strains.Conclusion The drug resistance of Candida glabrata to commonly used antifungals might be with an ascending trend.CDR1,CDR2 and ERG11 could be overexpressed in drug resistant strains of Candida glabrata,which might be closely correlated with fluconazole resistance.
出处 《国际检验医学杂志》 CAS 2012年第13期1559-1560,1564,共3页 International Journal of Laboratory Medicine
基金 广东省深圳市福田区公益性科研计划项目(FTWS049)
关键词 念珠菌 光滑 耐药性 基因 氟康唑 Candida glabrata; drug resistance; gene; fluconazole;
  • 相关文献

参考文献12

  • 1Martins HPR, Silva MLD, Paiva LCF, et al. Efficacy of Flucon- azole and Nystatin in the Treatment of Vaginal Candida Species [J]. Acta Derm Venereol, 2012,92 : 78-82.
  • 2Gygax SE, Vermitsky JP, Chadwick SG, et al. Antifungal Resist ance of Candida glabrata Vaginal Isolates and Development of a Quantitative Reverse Transeription-PCR-Based Azole Susceptibility Assay[J]. Antimierobial Agents and Chemotherapy, 2008,52(9):3424-3426.
  • 3Richter SS, Galask RP, Messer SA, et al. Antifungal Susceptibili- ties of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases[J]. J Clin Microbiol,2005,43(5) :2155-2162.
  • 4Borst A, Raimer MT,Warnoek DW. Rapid acquisition of stable az- ole resistance by Candida glabrata isolates obtained before the clinical introduction of flueonazole[J]. Antimicmb Agents Che- mother,2005,49(2) :783-787.
  • 5周晓维,张振国,乐宏元,刘晓虹.外阴阴道念珠菌病的病原检测及体外药敏试验[J].中国微生态学杂志,2009,21(8):759-759. 被引量:10
  • 6Bennett JE,Izumikawa K, Marr KA. Mechanism of increased flu- conazole resistance in Candida glabrata during prophylaxis[J]. Antimierob Agents Chemother, 2004,48(5):1773-1777.
  • 7Posteraro B, Sanguinetti M, Fiori B, et al. Caspofungin activity a- gainst clinical isolates of azole cross resistant Candida glabrata overexpressing efflux pump genes[J]. J Antimierob Chemother, 2006,58(2) :458-461.
  • 8Wada S, Tanabe K, Yamazaki A, et al. Phosphorylation of Candidaglabrata ATP binding cassette transporter Cdrlp regulates drug efflux activity and ATPase stability[J]. J Biol Chem, 2005,280 (1) :94-103.
  • 9Vermitsky JP, Edlind TD. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdrl Like transcription factor[J]. Antimicrob Agents Chemoth- er, 2004,48 (10):3773-3781.
  • 10Tsai HF, Krol AA, Sarti KE, et al. Candida glabrata PDRI, a transcriptional regulator of a pleiotropie drug resistance network, mediates azole resistance in clinical isolates and petite mutants [J]. Antimicrob Agents Chemother,2006,50(4) : 1384-1392.

二级参考文献19

  • 1刘小平,樊尚荣,李建武.妊娠期妇女外阴阴道念珠菌病的病原学和治疗研究[J].中华围产医学杂志,2004,7(4):220-222. 被引量:21
  • 2岳娜,田彬,徐海茹,胡志东.念珠菌性阴道炎患者临床感染念珠菌特点和药敏分析[J].天津医科大学学报,2005,11(3):384-385. 被引量:3
  • 3周俊英,叶临湘,付有荣.阴道感染酵母样真菌的鉴定及耐药性分析[J].医学新知,2005,15(4):22-24. 被引量:2
  • 4ARTEMIS念株菌属耐药性监测协作组,朱德妹,张婴元,汪复.中国5所医院念珠菌属对氟康唑和伏立康唑的耐药性监测[J].中国感染与化疗杂志,2007,7(1):14-18. 被引量:47
  • 5SOBEL J D, FAROS, FOME R W, et al. Vulvovaginal candidiasis epidemiologic diagnostic and therapeutic considerations [ J ]. Am J Obstet Gynecol, 1998,178 (2) :203-211.
  • 6PFALLER M A,JONES R N,DOERN G V, et al. Bloodstream infections due to candida species SENTRYantimicrobial sureuance program in North America and Latin America, 1997-1998 [ J]. Antionicrob Agents chemother,2000,44 ( 3 ) :747 -751.
  • 7Pfaller MA,Diekema DJ.Twelve years of fluconazole in clinical practice.global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.Clin Microbiol Infect,2004,10 Suppl 1:S11-23.
  • 8Pfaller MA,Pappas PG,Wingard JR.Invasive fungal pathogens:current epidemiological trends.Clin Infect Dis,2006,43 Suppl 1:S3-14.
  • 9Perea S,Patterson TF.Antifungal resistance in pathogenic fungi.Clin Infect Dis,2002,35:1073-1080.
  • 10White TC.Increased mRNA levels of ERG16,CDR,and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.Antimicrob Agents Chemother,1997,41:1482-1487.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部